PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

Sancak, Yasemin, Thoreen, Carson C., Peterson, Timothy R., Lindquist, Robert A., Kang, Seong A., Spooner, Eric, Carr, Steven A., Sabatini, David M.·2007·Molecular Cell
DOI 10.1016/j.molcel.2007.03.003

Cited by (1,000)

Items 501–600 of 1,000

  1. Signaling crosstalk between the mTOR complexes
    Jianling Xie, Christopher G. Proud · 2014 · Translation
  2. Anti-Myeloma Activity of Akt Inhibition Is Linked to the Activation Status of PI3K/Akt and MEK/ERK Pathway
    Vijay G. Ramakrishnan, Teresa K. Kimlinger, Jessica L. Haug, Utkarsh Painuly, Linda E. Wellik, Timothy M. Halling, S. Vincent Rajkumar, Shaji Kunnathu Kumar · 2012 · PLoS ONE
  3. Aberrant Hyperactivation of Akt and Mammalian Target of Rapamycin Complex 1 Signaling in Sporadic Chordomas
    Sangyeul Han, Carolyn Polizzano, G. Petur Nielsen, Francis John Hornicek, Andrew Eric Rosenberg, Vijaya Ramesh · 2009 · Clinical Cancer Research
  4. Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer’s disease
    Rafael Franco, Eva Martínez‐Pinilla, Gemma Navarro, Marta Zamarbide · 2017 · Progress in Neurobiology
  5. Cell signaling pathways as molecular targets to eliminate AML stem cells
    Ana Carolina Rodrigues, Rafaela G.A. Costa, Suellen L. R. Silva, Ingrid R. S. B. Dias, Rosane B. Dias, Daniel Pereira Bezerra · 2021 · Critical Reviews in Oncology/Hematology
  6. Enhancing mTOR-targeted cancer therapy
    Xuerong Wang, Shi‐Yong Sun · 2009 · Expert Opinion on Therapeutic Targets
  7. Dynamic Switch of Negative Feedback Regulation in Drosophila Akt–TOR Signaling
    Lutz Kockel, Kimberly S. Kerr, Michael Melnick, Katja Brückner, Matthias Hebrok, Norbert Perrimon · 2010 · PLoS Genetics
  8. Combination of Chemical Genetics and Phosphoproteomics for Kinase Signaling Analysis Enables Confident Identification of Cellular Downstream Targets
    Felix S. Oppermann, Kathrin Grundner‐Culemann, Chanchal Kumar, Oliver J. Gruß, Prasad V. Jallepalli, Henrik Daub · 2011 · Molecular & Cellular Proteomics
  9. The functions of mTOR in ischemic diseases
    Seo‐Kyoung Hwang, Hyung-Hwan Kim · 2011 · BMB Reports
  10. Mammalian target of rapamycin and the kidney. I. The signaling pathway
    Wilfred Lieberthal, Jerrold S. Levine · 2012 · American Journal of Physiology-Renal Physiology
  11. Rag GTPase in amino acid signaling
    Joungmok Kim, Eunjung Kim · 2016 · Amino Acids
  12. mTOR signaling: RAG GTPases transmit the amino acid signal
    Reuben J. Shaw · 2008 · Trends in Biochemical Sciences
  13. Tissue-Specific Coupling between Insulin/IGF and TORC1 Signaling via PRAS40 in Drosophila
    Cristina Pallares-Cartes, Gulcin Cakan‐Akdogan, Aurelio A. Teleman · 2012 · Developmental Cell
  14. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer
    Jianwei Wang, Shaojun Yu, Liming Cui, Wenhui Wang, Jun Li, Ke Wang, Xinyuan Lao · 2015 · BMC Cancer
  15. Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway
    Jonathan J. Havel, Zijian Li, D Cheng, J Peng, H Fu · 2014 · Oncogene
  16. AMP kinase (PRKAA1)
    Sukriti Krishan, Des Raymond Richardson, Sumit Sahni · 2014 · Journal of Clinical Pathology
  17. Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine
    Charles H. Lang, Robert A. Frost, Sarah K. Bronson, Christopher J. Lynch, Thomas C. Vary · 2010 · American Journal of Physiology-Endocrinology and Metabolism
  18. The role of nutrition in stimulating muscle protein accretion at the molecular level
    Scot R. Kimball · 2007 · Biochemical Society Transactions
  19. The mTOR signaling pathway as a treatment target for intracranial neoplasms
    Doreen Pachow, Wolfgang Wick, David H. Gutmann, C. Mawrin · 2014 · Neuro-Oncology
  20. Molecular Mechanisms Controlled by mTOR in Male Reproductive System
    Bruno P. Moreira, Pedro Fontes Oliveira, Marco Gouveia Alves · 2019 · International Journal of Molecular Sciences
  21. SnapShot: mTOR Signaling
    Alexandre Soulard, Michael N. Hall · 2007 · Cell
  22. Involvement of TGF-β and Autophagy Pathways in Pathogenesis of Diabetes: A Comprehensive Review on Biological and Pharmacological Insights
    Fatemeh Heydarpour, Soraya Sajadimajd, Elahe Mirzarazi, Pouya Haratipour, Tanuj Joshi, Mohammad Hosein Farzaei, Haroon Khan, Javier Echeverría · 2020 · Frontiers in Pharmacology
  23. m‐ TOR inhibitors and their potential role in haematological malignancies
    Teresa Calimeri, Andrés J.M. Ferreri · 2017 · British Journal of Haematology
  24. The Pathogenesis and Therapeutic Approaches of Diabetic Neuropathy in the Retina
    Toshiyuki Oshitari · 2021 · International Journal of Molecular Sciences
  25. Activation of the cardiac mTOR/p70 S6K pathway by leucine requires PDK1 and correlates with PRAS40 phosphorylation
    Cossette Sanchez Canedo, Bénédicte Demeulder, Audrey Ginion, José Ramón Bayascas, Jean‐Luc Balligand, Dario R. Alessi, Jean‐Louis Vanoverschelde, Christophe Beauloye, Louis Hue, Luc Bertrand · 2010 · American Journal of Physiology-Endocrinology and Metabolism
  26. Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle
    M. Rosner, Christiane Fuchs, Nicol Siegel, Alessandro Valli, Markus Hengstschläger · 2009 · Human Molecular Genetics
  27. Short inter-set rest blunts resistance exercise-induced increases in myofibrillar protein synthesis and intracellular signalling in young males
    McKendry, James, Pérez‐López, Alberto, McLeod, Michael, Luo, Dan, Dent, Jessica R., Smeuninx, Benoit, Yu, Jinglei, Taylor, Angela E., Philp, Andrew, Breen, Leigh · 2016 · Experimental Physiology
  28. The GATOR2–mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation
    A. H. Kowalsky, Sim Namkoong, Eric Mettetal, Hwan-Woo Park, D. Kazyken, D. Fingar, Jun-Hee Lee · 2020 · Journal of Biological Chemistry
  29. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1
    Jung Min Ha, Sung Ji Yun, Young Whan Kim, Seo Yeon Jin, Hye Sun Lee, Sang Heon Song, Hwa Kyoung Shin, Sun Sik Bae · 2015 · Biochemical and Biophysical Research Communications
  30. Current Models of Mammalian Target of Rapamycin Complex 1 (mTORC1) Activation by Growth Factors and Amino Acids
    Xu Zheng, Yan Liang, Qiburi He, Ruiyuan Yao, Wenlei Bao, Lili Bao, Yanfeng Wang, Zhigang Wang · 2014 · International Journal of Molecular Sciences
  31. Human Cytomegalovirus Infection Maintains mTOR Activity and Its Perinuclear Localization during Amino Acid Deprivation
    Amy J. Clippinger, Tobi G. Maguire, James C. Alwine · 2011 · Journal of Virology
  32. Understanding the mTOR signaling pathway via mathematical modeling
    Nurgazy Sulaimanov, Martin Klose, Hauke S. Busch, Melanie Boerries · 2017 · WIREs Systems Biology and Medicine
  33. Glucocorticoid-dependent REDD1 expression reduces muscle metabolism to enable adaptation under energetic stress
    Florian Alexis Britto, Fabienne Cortade, Yassine Belloum, Marine Blaquière, Yann Simon Gallot, Aurélie Docquier, Allan F. Pagano, Élodie Jublanc, Nadia Bendridi, Christelle Koechlin‐Ramonatxo et al. · 2018 · BMC Biology
  34. Regulation of mTORC1 by Small GTPases in Response to Nutrients.
    Min Zhu, Xiu-Qi Wang · 2020 · Journal of NutriLife
  35. Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives
    Marc Dufour, Anne Dormond-Meuwly, Nicolas Demartines, Olivier Dormond · 2011 · Cancers
  36. Hitting the Golden TORget: Curcumin’s Effects on mTOR Signaling
    Christopher S. Beevers, Hongyu Zhou, Shi-Le Huang · 2013 · Anti-Cancer Agents in Medicinal Chemistry
  37. AKT as a therapeutic target in multiple myeloma
    Niamh A Keane, Siobhan V. Glavey, Janusz Krawczyk, Michael E O'Dwyer · 2014 · Expert Opinion on Therapeutic Targets
  38. The role of amino acid-induced mammalian target of rapamycin complex 1(mTORC1) signaling in insulin resistance
    Mee-Sup Yoon, C. Choi · 2016 · Experimental and Molecular Medicine
  39. P2RX7-MAPK1/2-SP1 axis inhibits MTOR independent HSPB1-mediated astroglial autophagy
    Ji-Eun Kim, Ah-Reum Ko, Hye-Won Hyun, Su-Ji Min, Tae‐Cheon Kang · 2018 · Cell Death and Disease
  40. Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways
    Somayyeh Ghareghomi, Shahin Ahmadian, Nosratollah Zarghami, Houman Kahroba · 2020 · Biochimie
  41. Deptor Knockdown Enhances mTOR Activity and Protein Synthesis in Myocytes and Ameliorates Disuse Muscle Atrophy
    Abid A. Kazi, L. Hong-Brown, Susan M. Lang, Charles H. Lang · 2011 · Molecular Medicine
  42. Pulmonary lymphangioleiomyomatosis (LAM): Progress and current challenges
    Elena A. Goncharova, Vera P. Krymskaya · 2007 · Journal of Cellular Biochemistry
  43. Current Status and Challenges Associated with Targeting mTOR for Cancer Therapy
    Ryan J.O. Dowling, Michaël Pollak, Nahum Sonenberg · 2009 · BioDrugs
  44. Indole-3-acetic acid is a physiological inhibitor of TORC1 in yeast
    Raffaele Nicastro, Serena Raucci, Agnès H. Michel, M. Stumpe, Guillermo Miguel Garcia Osuna, Malika Jaquenoud, B. Kornmann, C. De Virgilio · 2021 · PLoS Genetics
  45. Elevated PI3K signaling drives multiple Breast Cancer subtypes
    Jessica R. Adams, Nathan F. Schachter, Jeff C. Liu, Eldad Zacksenhaus, Sean E. Egan · 2011 · Oncotarget
  46. The mechanical activation of mTOR signaling: an emerging role for late endosome/lysosomal targeting
    Brittany L. Jacobs, Craig A. Goodman, Troy Alan Hornberger · 2013 · Journal of Muscle Research and Cell Motility
  47. Therapeutic Implications of Targeting AKT Signaling in Melanoma
    SubbaRao V. Madhunapantula, Gavin P. Robertson · 2011 · Enzyme Research
  48. Sepsis-Induced Alterations in Protein-Protein Interactions Within mTOR Complex 1 and the Modulating Effect of Leucine on Muscle Protein Synthesis
    Abid A. Kazi, Anne M. Pruznak, Robert A. Frost, Charles H. Lang · 2010 · Shock
  49. Emerging Role of mTOR Signaling‐Related miRNAs in Cardiovascular Diseases
    Arun Samidurai, Rakesh C. Kukreja, Anindita Das · 2018 · Oxidative Medicine and Cellular Longevity
  50. Hydrogen peroxide impairs insulin-stimulated assembly of mTORC1
    Lianqin Zhang, Scot R. Kimball, Leonard S. Jefferson, Jeffrey S. Shenberger · 2009 · Free Radical Biology and Medicine
  51. Location-specific inhibition of Akt reveals regulation of mTORC1 activity in the nucleus
    Xin Zhou, Yanghao Zhong, Olivia Molinar‐Inglis, Maya T. Kunkel, Ming‐Yuan Chen, Tengqian Sun, Jiao Zhang, John Y.-J. Shyy, JoAnn Trejo, Alexandra C. Newton et al. · 2020 · Nature Communications
  52. Tuberous sclerosis complex: linking cancer to metabolism
    Virginie Mieulet, Richard F. Lamb · 2010 · Trends in Molecular Medicine
  53. GILZ inhibits the mTORC2/AKT pathway in BCR-ABL+ cells
    Sami Joha, A-L Nugues, Dominique Hétuin, Céline Berthon, Xavier Dezitter, Véronique Dauphin, François‐Xavier Mahon, Catherine Roche‐Lestienne, Claude Preudhomme, Bruno Quesnel et al. · 2011 · Oncogene
  54. mTOR signaling in neural stem cells: from basic biology to disease
    Laura Magri, Rossella Galli · 2012 · Cellular and Molecular Life Sciences
  55. microRNA-21-induced dissociation of PDCD4 from rictor contributes to Akt-IKKβ-mTORC1 axis to regulate renal cancer cell invasion
    Amit Bera, Falguni Das, Nandini Ghosh‐Choudhury, Balakuntalam S. Kasinath, Hanna E. Abboud, Goutam Ghosh Choudhury · 2014 · Experimental Cell Research
  56. Autophagy: from basic science to clinical application
    J. van Limbergen, C. Stevens, E. Nimmo, DC Wilson, J. Satsangi · 2009 · Mucosal Immunology
  57. A modelling–experimental approach reveals insulin receptor substrate (IRS)‐dependent regulation of adenosine monosphosphate‐dependent kinase (AMPK) by insulin
    Annika Sonntag, Piero Dalle Pezze, Daryl P. Shanley, Kathrin Thedieck · 2012 · FEBS Journal
  58. Rethinking phosphatidylinositol 3-monophosphate
    Marco Falasca, Tania Maffucci · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  59. The mTOR Signalling Pathway in Cancer and the Potential mTOR Inhibitory Activities of Natural Phytochemicals
    Heng Kean Tan, Ahmed Ismail Hassan Moad, Mei Lan Tan · 2014 · Asian Pacific Journal of Cancer Prevention
  60. Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells
    Yoshinobu Odaka, Baoshan Xu, Yan Luo, Tao Shen, Chaowei Shang, Yang Wu, Hongyu Zhou, Shile Huang · 2013 · Carcinogenesis
  61. AKTivation mechanisms
    Philip A. Cole, Nam Ky Chu, Antonieta L. Salguero, Hwan Bae · 2019 · Current Opinion in Structural Biology
  62. Regulation of mTORC1 by the Rag GTPases
    Tshering D. Lama-Sherpa, Mi‐Hyeon Jeong, Jenna L. Jewell · 2023 · Biochemical Society Transactions
  63. ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation
    Alejandro Parrales, Edith López, Irene Lee-Rivera, Ana Marı́a López-Colomé · 2013 · Cellular Signalling
  64. Mammalian target of rapamycin (mTOR): a central regulator of male fertility?
    Tito T. Jesus, Pedro Fontes Oliveira, Mário Sousa, C. Yan Cheng, Marco Gouveia Alves · 2017 · Critical Reviews in Biochemistry and Molecular Biology
  65. ZRF1 is a novel S6 kinase substrate that drives the senescence programme
    Manuela Barilari, Grégory Bonfils, Caroline Treins, Vonda Koka, Delphine De Villeneuve, Sylvie Fabrega, Mario Pende · 2017 · The EMBO Journal
  66. DEPDC5 as a potential therapeutic target for epilepsy
    Kenneth Alexis Myers, Ingrid Eileen Scheffer · 2017 · Expert Opinion on Therapeutic Targets
  67. Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment
    A. Hage, Olivier Dormond · 2021 · Cancers
  68. Targeting the mTOR Pathway Using Deforolimus in Cancer Therapy
    Devalingam Mahalingam, Kamalesh Kumar Sankhala, Alain C. Mita, Francis Joseph Giles, Monica M Mita · 2009 · Future Oncology
  69. Cyclic AMP Inhibits the Proliferation of Thyroid Carcinoma Cell Lines through Regulation of CDK4 Phosphorylation
    Ana Sofia Rocha, Sabine Paternot, Katia Coulonval, Jacques E. Dumont, Paula Soares, Pierre P. Roger · 2008 · Molecular Biology of the Cell
  70. Dynein mediates the localization and activation of mTOR in normal and human cytomegalovirus-infected cells
    Amy J. Clippinger, James C. Alwine · 2012 · Genes & Development
  71. Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2
    Dapeng Li, Anjiang Sun, Liang N. Zhang, Zhao Ding, Fangzheng Yi, Zixi Wang, Zixi Wang, Xu Chen, Shixian Liu, Shixian Liu et al. · 2022 · Theranostics
  72. Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics
    Naif Alqurashi, Saeed M. Hashimi, Ming Qian Wei · 2013 · International Journal of Molecular Sciences
  73. Conserved and Divergent Mechanisms That Control TORC1 in Yeasts and Mammals
    Yuichi Morozumi, Kazuhiro Shiozaki · 2021 · Genes
  74. Nuclear dihydroxyacetone phosphate signals nutrient sufficiency and cell cycle phase to global histone acetylation
    Jiaojiao Zhang, Tingting Fan, Yun-Zi Mao, Jun‐Li Hou, Meng Wang, Min Zhang, Yan Lin, Lei Zhang, Guoquan Yan, Yanpeng An et al. · 2021 · Nature Metabolism
  75. Mitochondrial hyperfusion via metabolic sensing of regulatory amino acids
    Mahmud O. Abdullah, Run X. Zeng, Chelsea L. Margerum, David J. Papadopoli, Cian Monnin, Kaylee B. Punter, Charles Chu, Mohammad Al-Rofaidi, Naser F. Al‐Tannak, Domenica Berardi et al. · 2022 · Cell Reports
  76. Rheb (Ras Homologue Enriched in Brain)-dependent Mammalian Target of Rapamycin Complex 1 (mTORC1) Activation Becomes Indispensable for Cardiac Hypertrophic Growth after Early Postnatal Period
    Takahito Tamai, Osamu Yamaguchi, Shungo Hikoso, Toshihiro Takeda, Manabu Taneike, Takafumi Oka, Jota Oyabu, Tomokazu Murakawa, Hiroyuki Nakayama, Yoshihiro Uno et al. · 2013 · Journal of Biological Chemistry
  77. Regulation of mTORC1 Signaling by Src Kinase Activity Is Akt1-Independent in RSV-Transformed Cells
    Martina Vojtěchová, Jolana Turečková, Dana Kučerová, Eva Šloncová, J Vachtenheim, Zdena Tuháčková · 2008 · Neoplasia
  78. PTEN negatively regulates mTORC2 formation and signaling in grade IV glioma via Rictor hyperphosphorylation at Thr1135 and direct the mode of action of an mTORC1/2 inhibitor
    K Bhattacharya, Samarpan Maiti, Chitra Mandal · 2016 · Oncogenesis
  79. Chapter 12 Serine Kinases of Insulin Receptor Substrate Proteins
    Sigalit Boura‐Halfon, Yehiel Zick · 2009 · Vitamins and hormones
  80. CCL2 Is a Negative Regulator of AMP-Activated Protein Kinase to Sustain mTOR Complex-1 Activation, Survivin Expression, and Cell Survival in Human Prostate Cancer PC3 Cells
    Hernan Roca, Zachary S. Varsos, Kenneth J. Pienta · 2009 · Neoplasia
  81. PRAS40 acts as a nodal regulator of high glucose‐induced TORC1 activation in glomerular mesangial cell hypertrophy
    Nirmalya Dey, Nandini Ghosh‐Choudhury, Falguni Das, Xiaonan Li, Balachandar A. Venkatesan, Jeffrey L. Barnes, Balakuntalam S. Kasinath, Goutam Ghosh Choudhury · 2010 · Journal of Cellular Physiology
  82. Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer
    Ritu Malla, Charles R. Ashby, Narayanan K. Narayanan, Bhagavathi A. Narayanan, Jesika S. Faridi, Amit Kumar Tiwari · 2015 · Biochemical and Biophysical Research Communications
  83. Translational control by oncogenic signaling pathways.
    Beichen Gao, Philippe P Roux · 2015 · Biochimica et Biophysica Acta
  84. The Role of PI3K in Met Driven Cancer: A Recap
    Alexia Hervieu, Stéphanie Kermorgant · 2018 · Frontiers in Molecular Biosciences
  85. Edaravone and Acetovanillone Upregulate Nrf2 and PI3K/Akt/mTOR Signaling and Prevent Cyclophosphamide Cardiotoxicity in Rats
    Emad H. M. Hassanein, Omnia A. M. Abd El‐Ghafar, Marwa A. Ahmed, Ahmed Mahmoud Mohammed Sayed, Wail M. Gad-Elrab, Jamaan Said Ajarem, Ahmed A. Allam, Ayman Moawad Mahmoud · 2020 · Drug Design Development and Therapy
  86. Osmotic Stress Regulates Mammalian Target of Rapamycin (mTOR) Complex 1 via c-Jun N-terminal Kinase (JNK)-mediated Raptor Protein Phosphorylation
    Dongoh Kwak, Sunkyu Choi, Heeyoon Jeong, Jin‐Hyeok Jang, Youngmi Lee, Hyeona Jeon, Mi Nam Lee, Jungeun Noh, Kun Cho, Jong Shin Yoo et al. · 2012 · Journal of Biological Chemistry
  87. Mechanistic Target of Rapamycin Complex 1: From a Nutrient Sensor to a Key Regulator of Metabolism and Health
    Guoyan Wang, Lei Chen, Senlin Qin, Tingting Zhang, Junhu Yao, Yanglei Yi, Lu Deng · 2022 · Advances in Nutrition
  88. Structural basis for mTORC1 activation on the lysosomal membrane
    Zhicheng Cui, Alessandra Esposito, Gennaro Napolitano, Andrea Ballabio, James H. Hurley · 2025 · Nature
  89. High glucose enhances microRNA-26a to activate mTORC1 for mesangial cell hypertrophy and matrix protein expression
    Nirmalya Dey, Amit Bera, Falguni Das, Nandini Ghosh‐Choudhury, Balakuntalam S. Kasinath, Goutam Ghosh Choudhury · 2015 · Cellular Signalling
  90. Partial Support Ventilation and Mitochondrial-Targeted Antioxidants Protect against Ventilator-Induced Decreases in Diaphragm Muscle Protein Synthesis
    Matthew B. Hudson, Ashley J. Smuder, W. Bradley Nelson, Michael P. Wiggs, Kevin L. Shimkus, James D. Fluckey, Hazel H. Szeto, Scott K. Powers · 2015 · PLoS ONE
  91. PRAS40 Regulates Protein Synthesis and Cell Cycle in C2C12 Myoblasts
    Abid A. Kazi, Charles H. Lang · 2010 · Molecular Medicine
  92. mTORC2 Signaling: A Path for Pancreatic β Cell's Growth and Function
    Ting Yuan, Blaž Lupše, Kathrin Maedler, Amin Dakhili Ardestani · 2018 · Journal of Molecular Biology
  93. Rag GTPases and AMPK/TSC2/Rheb mediate the differential regulation of mTORC1 signaling in response to alcohol and leucine
    Ly Q. Hong‐Brown, C. Randell Brown, Abid A. Kazi, Maithili Navaratnarajah, Charles H. Lang · 2012 · American Journal of Physiology-Cell Physiology
  94. The mTOR Signaling Pathway Interacts with the ER Stress Response and the Unfolded Protein Response in Cancer
    Sahar Mafi, Elham Ahmadi, Eileen Victoria Meehan, Conner C. Chiari, Behzad Mansoori, Hossein Sadeghi, Sahar Milani, Morteza Jafarinia, Shahram Taeb, Bayan Mafakheri Bashmagh et al. · 2023 · Cancer Research
  95. Malonyl-CoA is a conserved endogenous ATP-competitive mTORC1 inhibitor
    Raffaele Nicastro, Laura Brohée, Josephine Alba, Julian Nüchel, Gianluca Figlia, Stefanie Kipschull, Peter Gollwitzer, Jesús Romero‐Pozuelo, Stephanie Fernandes, Andreas A. Lamprakis et al. · 2023 · Nature Cell Biology
  96. Characterization of the Rheb‐mTOR Signaling Pathway in Mammalian Cells: Constitutive Active Mutants of Rheb and mTOR
    Tatsuhiro Sato, Akiko Umetsu, Fuyuhiko Tamanoi · 2008 · Methods in enzymology on CD-ROM/Methods in enzymology
  97. The Mechanism of Insulin-stimulated 4E-BP Protein Binding to Mammalian Target of Rapamycin (mTOR) Complex 1 and Its Contribution to mTOR Complex 1 Signaling
    Joseph Rapley, Noriko Oshiro, Sara Ortiz-Vega, Joseph Avruch · 2011 · Journal of Biological Chemistry
  98. Key mediators of intracellular amino acids signaling to mTORC1 activation
    Yehui Duan, Fengna Li, Kunrong Tan, Hongnan Liu, Yinghui Li, Yingying Liu, Xiangfeng Kong, Yulong Tang, Guoyao Wu, Yulong Yin · 2015 · Amino Acids
  99. Development of a FRET Biosensor with High Specificity for Akt
    Haruko Miura, Michiyuki Matsuda, Kazuhiro Aoki · 2013 · Cell Structure and Function
  100. What controls TOR?
    Estela Jacinto · 2008 · IUBMB Life